News

Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology

December 08, 2017

REDWOOD CITY, Calif. , Dec. 08, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical ...

Read More

Soleno Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference

November 22, 2017

REDWOOD CITY, Calif. , Nov. 22, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical ...

Read More

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

November 14, 2017

Completed Successful EMA Meeting for DCCR in Prader-Willi Syndrome Continued Preparations to Begin Phase III ...

Read More
Soleno – Home